Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| Upstream (Parents) |
|---|
| (<<) CNR2 → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| (<<) SIN3B → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| (<<) CIZ1 → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| (<<) SOD3 → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| (<<) SEPT8 → SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 |
| Downstream (Children) |
|---|
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → CNR2 (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → ABI2 (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → ADAM3B (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → DBC1 (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → ANK2 (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → VPS13C (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → CNTNAP3B (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → SLC12A4 (>>) |
| SSX10///SSX2B///SSX9///SSX7///SSX3///SSX5///SSX2///SSX1 → SCN10A (>>) |
